A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Gabapentin Enacarbil in Subjects with Neuropathic Pain Associated with Postherpetic Neuralgia (PXN110748)

Journal of Pain

Volumn 14, Issue 6, 2013, Pages 590-603

  Zhang, Lixin ^a   Rainka, Michelle ^a   Freeman, Roy ^b   Harden, R Norman ^c   Bell, Christopher F ^d   Chen, Chao ^d   Graff, Ole ^d   Harding, Kathleen ^d   Hunter, Setrina ^d   Kavanagh, Sarah ^d   Laurijssens, Bart ^e   Schwartzbach, Caryl ^d   Warren, Samantha ^d   McClung, Carrie ^d  

^a DENT NEUROLOGIC INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c REHABILITATION INSTITUTE OF CHICAGO   (United States)

^d GLAXOSMITHKLINE   (United States)

^e BEL Pharm Consulting   (France)

Author keywords

gabapentin; gabapentin enacarbil; herpes zoster; neuropathic pain; Postherpetic neuralgia

Indexed keywords

GABAPENTIN ENACARBIL;

ADULT; AGED; ARTHRALGIA; ARTICLE; BACKACHE; BLURRED VISION; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; EDEMA; FATIGUE; FEMALE; FLATULENCE; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEUROPATHIC PAIN; NOSE OBSTRUCTION; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SHORT FORM 36; SIDE EFFECT; SLEEP TIME; SOMNOLENCE; SPRAIN; TREATMENT RESPONSE; TREMOR; URINARY TRACT INFECTION; WEIGHT; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANESTHETICS; CARBAMATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878360498     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2013.01.768     Document Type: Article

References (24)

1. H.N. Bockbrader Clinical pharmacokinetics of gabapentin Drugs Today 31 1995 613 619
2. K.C. Cundy, S. Sastry, W. Luo, J. Zou, T.L. Moors, and D.M. Cannafax Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin J Clin Pharmacol 48 2008 1378 1388
3. M. Cunnington The incidence and prevalence of neuropathic pain GlaxoSmithkline Rx Communications 2004 1 46
4. R.H. Dworkin, A.E. Corbin, J.P. Young Jr., U. Sharma, L. LaMoreaux, H. Bockbrader, E.A. Garofalo, and R.M. Poole Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial Neurology 60 2003 1274 1283
5. R.H. Dworkin, R.W. Johnson, J. Breuer, J.W. Gnann, M.J. Levin, M. Backonja, R.F. Betts, A.A. Gershon, M.L. Haanpaa, M.W. McKendrick, T.J. Nurmikko, A.L. Oaklander, M.N. Oxman, D.P. Langston, K.L. Petersen, M.C. Rowbotham, K.E. Schmader, B.R. Stacey, S.K. Tyring, A.J.M. van Wijck, M.S. Wallace, S.W. Wassilew, and R.J. Whitley Recommendations for the management of herpes zoster Clin Infect Dis 44 2007 S1 26
6. R.H. Dworkin, D.C. Turk, J.T. Farrar, J.A. Haythornthwaite, M.P. Jensen, N.P. Katz, R.D. Kerns, G. Stucki, R.R. Allen, N. Bellamy, D.B. Carr, J. Chandler, P. Cowan, R. Dionne, B.S. Galer, S. Hertz, A.R. Jadad, L.D. Kramer, D.C. Manning, S. Martin, C.G. McCormick, M.P. McDermott, P. McGrath, S. Quessy, B.A. Rappaport, W. Robbins, J.P. Robinson, M. Rothman, M.A. Royal, L. Simon, J.W. Stauffer, W. Stein, J. Tollett, J. Wernicke, and J. Witter Core outcome measures for chronic pain clinical trials: IMMPACT recommendations Pain 113 2005 9 19
7. R.H. Dworkin, D.C. Turk, M.P. McDermott, S. Peirce-Sandner, L.B.B. Burke, P. Cowan, J.T. Farrar, S. Hertz, S.N. Raja, B.A. Rappaport, C. Rauschkolb, and C. Sampaio Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations Pain 146 2009 238 244
8. R.H. Dworkin, D.C. Turk, D.A. Revicki, G. Harding, K.S. Coyne, S. Peirce-Sandner, D. Bhagwat, D. Everton, L.B. Burke, P. Cowan, J.T. Farrar, S. Hertz, M.B. Max, B.A. Rappaport, and R. Melzack Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2) Pain 144 2009 35 42
9. J.T. Farrar, J.P. Young, L. Lamoreaux, J. Weth, and R.M. Poole Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 94 2001 149 158
10. Horizant (gabapentin enacarbil) Prescribing Information Research Triangle Park (NC) and Santa Clara (CA): GlaxoSmithKline and XenoPort, Inc. Available at http://us.gsk.com/products/assets/us-horizant.pdf. Accessed 1 June 2012
11. G. Irving, M. Jensen, M. Cramer, J. Wu, Y.K. Chiang, M. Tark, and M. Wallace Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: Results of a double-blind, randomized, placebo-controlled clinical trial Clin J Pain 25 2009 185 192
12. M.P. Jensen, Y. Chiang, and J. Wu Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia Clin J Pain 25 2009 286 292
13. R.G. Kost, and S.E. Straus Postherpetic neuralgia-pathogenesis, treatment and prevention N Engl J Med 335 1996 32 42
14. R. Lal, J. Sukbuntherng, W. Luo, J. Tovera, M. Liesse Lassauzet, and K.C. Cundy Population pharmacokinetics and pharmacodynamics of gabapentin after administration of gabapentin enacarbil J Clin Pharmacol 2012 Mar 15 [Epub ahead of print]
15. P.A. Lockwood, J.A. Cook, W.E. Ewy, and J.W. Mandema The use of clinical trial simulation to support dose selection: Application to development of a new treatment for chronic neuropathic pain Pharm Res 20 2003 1752 1759
16. Neurontin (gabapentin) Prescribing Information. New York (NY): Pfizer, Inc. Available at http://labeling.pfizer.com/ShowLabeling.aspx?id=630. Accessed 1 Mar 2012
17. A.B. O'Connor, and R.H. Dworkin Treatment of Neuropathic Pain: An overview of Recent Guidelines Am J Med 122 2009 S22 S32
18. A.S.C. Rice, S. Maton Postherpetic Neuralgia Study Group Gabapentin in postherpetic neuralgia: A randomized double blind, placebo controlled study Pain 94 2001 215 224
19. M. Rowbotham, N. Harden, B. Stacey, P. Bernstein, and L. Magnus-Miller Gabapentin for the treatment of postherpetic neuralgia. A randomized controlled trial JAMA 280 1998 1837 1842
20. R. Sabatowski, R. Galvez, D.A. Cherry, F. Jacquot, E. Vincent, P. Maisonobe, M. Versavel The 1008-045 Study Group Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial Pain 109 2004 26 35
21. R. van Seventer, H.A. Feister, J.P. Young Jr., M. Stoker, M. Versavel, and L. Rigaudy Efficacy and tolerability of twicedaily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: A 13-week, randomized trial Curr Med Res Opin 22 2006 375 384
22. M.S. Wallace, G. Irving, and V.E. Cowles Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: A randomized, double-blind, placebo-controlled, multicentre study Clin Drug Investig 30 2010 765 776
23. ® System 1999 Books by Users Cary, NC
24. L. Young Post-herpetic-neuralgia: A review of advances in treatment and prevention J Drugs Dermatol 5 2006 938 941